Well there you have it folks. We've been here beforeBut it almost looks like this time we are here to stay. Zero promises to deliver on, zero positive news in the pipeline - labs doesn't count, it was promised months ago. 50% more dilution than the last run down, way too much cheap paper, and will be running low on cash by end of year. Margins in the next fins will tell us all we need to know.